This indicates that there is a FAS-independent, unknown factor which prevents CD8-positive TILs from functioning in ER-positive breast cancer Furthermore, since FAS itself is prognostic in ER-positive breast cancer, it indicates that there are more anti-tumor mechanisms of FAS expression besides the T-cell mediated immunity, which were described in detail earlier [27]. Here, FAS is linked to neoplasm.